12-Acetoxyhawtriwaic Acid Lactone, a Diterpene from Egletes viscosa, Attenuates Capsaicin-Induced Ear Edema and Hindpaw Nociception in Mice: Possible Mechanisms

Abstract

The diterpene, 12-acetoxyhawtriwaic acid lactone (AHAL, tanabalin) isolated from the flower buds of Egletes viscosa Less. (Asteraceae) was evaluated on capsaicin-induced ear edema and hindpaw nociception in mice. AHAL (12.5, 25 and 50 mg/kg, p. o.) significantly attenuated the ear edema response to topically applied capsaicin (250 μg), in a dose-related manner. At similar doses, AHAL also suppressed the nocifensive paw-licking behavior induced by intraplantar injection of capsaicin (1.6 μg). These responses to capsaicin were also greatly inhibited by ruthenium red (3 mg/kg, s. c.), a non-competitive capsaicin receptor (TRPV1) antagonist. The anti-edema effect of AHAL (50 mg/kg) seems unrelated to either blockade of mast cell degranulation or to histamine and serotonin receptor antagonism since AHAL did not modify the paw edema response induced by intraplantar injections of compound 48/80, histamine or serotonin. However, the hindpaw edema induced by substance P and vascular permeability increase induced by intraperitoneal acetic acid were significantly suppressed by AHAL. The antinociceptive effect of AHAL (50 mg/kg) was unaffected by naloxone pretreatment but was significantly antagonized by theophylline and glibenclamide, the respective blockers of adenosine and K_ATP-channels. AHAL (50 mg/kg, p. o.) did not impair the ambulation or motor coordination of mice in open-field and rota-rod tests. These data suggest that AHAL inhibits acute neurogenic inflammation possibly involving capsaicin-sensitive TRPV1-receptors, endogenous adenosine and ATP-sensitive potassium channels.

Egletes viscosa - 12-acetoxyhawtriwaic acid lactone - tanabalin - capsaicin - antiedema - antinociception

References

• 1 Corrêa P. Dicionário de plantas uteis do Brasil e das exóticas cultivadas. Vol. 5 Rio de Janeiro; Imprensa Nacional, Instituto Brasileiro de Desenvolvimento Florestal 1984
• 2 Lima M A, Silveira E R, Marques M S, Santos R H, Gambardela M T. Biologically active flavonoids and terpenoids from Egletes viscosa.  Phytochemistry. 1996;  41 217-23
• 3 Souza M F, Tome A R, Rao V SN. Inhibition by the bioflavonoid ternatin of aflatoxin B₁-induced lipid peroxidation in rat liver.  J Pharm Pharmacol. 1999;  51 125-9
• 4 Caterina M J, Leffler A, Malmberg A B, Martin W J, Trafton J, Petersen-Zeitz K R. et al . Impaired nociception and pain sensation in mice lacking the capsaicin receptor.  Science. 2000;  288 306-13
• 5 Szolesanyi J. Forty years in capsaicin research for sensory pharmacology and physiology.  Neuropeptides. 2004;  38 377-84
• 6 Holzer P. Vanilloid receptor TRPV1: hot on the tongue and inflaming the colon.  Neurogastroenterol Motil. 2004;  16 697-9
• 7 Guedes M M, Cunha A N, Silveira E R, Rao V SN. Antinociceptive and gastroprotective effects of diterpenes from the flower buds of Egletes viscosa .  Planta Med. 2002;  68 1044-6
• 8 Ueda H. Molecular mechanism of neuropathic pain-phenotypic switch and initiation mechanisms.  Pharmacol Ther. 2006;  18 57-77
• 9 Mantione C R, Rodriguez R. A bradykinin (BK) 1 receptor antagonist blocks capsaicin-induced ear inflammation in mice.  Br J Pharmacol. 1990;  99 516-8
• 10 Whittle B A. The use of changes in capillary permeability in mice to distinguish between narcotic and non-narcotic analgesics.  Br J Pharmacol. 1964;  22 246-53
• 11 Henriques M G, Silva P M, Martins M A, Flores C A, Cunha F Q, Assreuy-Filho J. et al . Mouse paw edema.  A new model for inflammation? Braz J Med Biol Res. 1987;  20 243-9
• 12 Kassuya C A, Leite D F, de Melo L V, Rehder V L, Calixto J B. Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus .  Planta Med. 2005;  71 721-6
• 13 Santos A R, Calixto J B. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice.  Neuropeptides. 1997;  37 381-9
• 14 Capaz F R, Vanconcellos L M, De Moraes S, Neto J P. The use of changes in capillary permeability in mice to distinguish between narcotic and non-narcotic analgesics.  Arch Int Pharmacodyn Ther. 1981;  251 228-36
• 15 Rosland J H, Hunskaar S, Hole K. Diazepam attenuates morphine antinociception test-dependently in mice.  Pharmacol Toxicol. 1990;  66 382-6
• 16 Grant A D, Gerard N P, Brain S D. Evidence of a role for NK1 and CGRP receptors in mediating neurogenic vasodilatation in the mouse ear.  Br J Pharmacol. 2002;  135 356-62
• 17 Sterner O, Szallasi A. Novel natural vanilloid receptor agonists: new therapeutic targets for drug development.  Trends Pharmacol Sci. 1999;  20 459-65
• 18 Lecci A, Giuliani S, Tramontana M, Carini F, Maggi C A. Peripheral actions of tachykinins.  Neuropeptides. 2000;  34 303-13
• 19 De Jesus R A, Cechinel-Filho V, Oliveira A E, Schlemper V. Analysis of the antinociceptive properties of marrubiin isolated from Marrubium vulgare .  Phytomedicine. 2000;  7 111-5
• 20 Ocana M, Cendan C M, Cobos E J, Entrena J M, Baeyens J M. Potassium channels and pain: present realities and future opportunities.  Eur J Pharmacol. 2004;  500 203-19
• 21 Puntambekar P, Van Buren J, Raisinghani M, Premkumar L S, Ramkumar V. Direct interaction of adenosine with the TRPV1 channel protein.  J Neurosci. 2004;  24 3663-71
• 22 Ocana M, Baeyens J M. Role of ATP-sensitive K⁺ channels in antinociception induced by R-PIA, an adenosine A₁ receptor agonist.  Naunyn Schmiedebergs Arch Pharmacol. 1994;  350 57-62